Hydrogel Dressing Market (By Product: Amorphous Hydrogel, Impregnated Hydrogel; By Application: Acute Wounds, Chronic Wounds; By End Use: Hospitals, Specialty Clinics) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

The global hydrogel dressing market was surpassed at USD 849.43 million in 2021 and is expected to hit around USD 1.33 billion by 2030, growing at a CAGR of 5.11% from 2022 to 2030.

Hydrogel Dressing Market Size 2021 to 2030

Report Highlights

  • Based on product, the amorphous hydrogel segment is anticipated to capture 50.5% of the total market share in 2021 and is expected to dominate the product segment over the forecast period. 
  • The chronic wounds segment dominated the hydrogel market and accounted for a revenue share of 60.1% in 2021, and is projected to show a considerable growth rate over forecast years. 
  • The acute wound segment is projected to witness the fastest CAGR of 4.51% during the forecast years. 
  • The hospital segment held the largest revenue share of 45.33% in 2021. 
  • The home healthcare segment is anticipated to witness the fastest CAGR of 4.95% during the forecast period.
  • North America dominated the hydrogel dressing market with a revenue share of 45.51% in 2021 and is expected to witness a considerable growth rate in the forecast period. 
  • Asia Pacific is estimated to witness the highest CAGR of 4.95% during the forecast period. 

The market growth can be accredited to the rising prevalence of chronic wounds globally. The properties of hydrogel-based dressings can be adjusted much more easily compared to conventional chronic wound therapy methods. Moreover, owing to their adaptability and versatility, hydrogel dressings can be loaded with cells, antibacterial, antiviral, and antifungal agents, growth factors, and biomolecules to hasten wound contraction and healing. Furthermore, their ability to create in situ and cytocompatible chemical crosslinking these dressings may be easily applied to irregular or deep wounds. Thereby, owing to the above-mentioned advantages is expected to impel the hydrogel dressing market.

Massive research is being conducted in order to create novel hydrogel products from natural sources such as animal tissues, plant extracts, extracellular matrix, and others. Firms are extensively spending on R&D and are continuously working on achieving positive clinical trial results. For instance, Remedor Biomed Ltd. is conducting clinical studies on a hydrogel containing erythropoietin to treat diabetic foot ulcers. In addition, a variety of peptides are being studied in clinical studies for their wound-healing abilities. Thus, rigorous clinical studies to commercialize novel hydrogel dressing products are expected to drive the growth of the hydrogel dressing market in the near term.

Additionally, the number of burn injuries is rising globally. For instance, above 30,000 burn cases are reported daily worldwide, according to NCBI. Hydrogel dressings may provide an alternative to cooling burn wounds with streaming water, particularly in circumstances of mass casualty disasters, a lack of clean water, hypothermia, or extensive burns. They evaporate the heat that has accumulated in the skin. This dressing provides a better healing effect in burns owing to higher water content. Therefore, the hydrogel dressings market is likely to be fueled due to the increasing number of burn cases in the forecast period.

Scope of The Report

Report Coverage Details
Market Size in 2021 USD 849.43 million
Revenue Forecast by 2030 USD 1.33 billion  
Growth rate from 2022 to 2030 CAGR of 5.11%
Base Year 2021
Forecast Period 2022 to 2030
Segmentation Product, application, end-use, region
Companies Covered

Cardinal Health; Smith & Nephew; 3M; Coloplast Corp.; ConvaTec Group PLC; Medline Industries; Integra LifeSciences Corp.; McKesson Medical-Surgical; DermaRite Industries, LLC; AMERX Health Care Corp.

 

Product Insights

Based on product, the amorphous hydrogel segment is anticipated to capture 50.5% of the total market share in 2021 and is expected to dominate the product segment over the forecast period. Amorphous hydrogel dressing is used to provide moisture to a dry wound and retain a moist healing environment. These dressings are commonly used in minor burns, and necrotic wounds, and to heal tissue damaged due to radiation. There has been an increasing number of people suffering from burns globally which are expected to increase the demand for hydrogel dressings. According to an article posted by American Burn Association in February 2021, more than 400,000 people in the U.S. annually receive treatment for burn injuries. Similarly, as per the WHO, every year, thermal burn is estimated to affect 6.6 million people worldwide. Hence, due to the above-mentioned factors, the amorphous hydrogel segment is anticipated to have a considerable growth rate during the forecast years.

Impregnated hydrogel dressing is used for recovery of partial & full thickness wounds, and deep wounds such as skin tears. The rising incidence and prevalence of skin tears are anticipated to boost the use of hydrogel dressing. For instance, as per a study conducted by NCBI in Ontario, out of the total individuals registered in the study, the prevalence of skin tears was found to be 20.8%, with an incidence rate of 18.9% during the four weeks of the study. Similarly, as per the latest available statistics by World Population Review, knife-related deaths in South Africa touched 16.95 per 100,000 population, whereas, India ranked 3rd in top 10 countries with the most deaths due to stabbing along with deaths of around 8,931 people. Stab wounds require to be kept moist for quick recovery. Thus, with rising cases of acute wounds such as skin tears, and stab wounds, the segment is forecasted to have a significant growth rate.

Application Insights

The chronic wounds segment dominated the hydrogel market and accounted for a revenue share of 60.1% in 2021, and is projected to show a considerable growth rate over forecast years. The dominance can be accredited to the rise in the geriatric population, the increase in the number of people suffering from diabetic foot ulcers, and obesity. The surge in the number of people suffering from obesity is expected to impel the number of patients suffering from pressure ulcers and venous leg ulcers. For instance, according to an article published by Trust for America’s Health organization in September 2021, the obesity rate in 16 states of the U.S. as of 2020 was above 35%. As obesity is associated with the increasing prevalence of pressure ulcers, the use of hydrogel dressing is anticipated to increase over the forecast period.

However, the acute wound segment is projected to witness the fastest CAGR of 4.51% during the forecast years. The primary element fueling the segment's rise is the increase in cases of various traumatic injuries, including gunshot wounds, lacerations, stab wounds, and accidents. For instance, the Pew Research Center estimates that 45,222 Americans died from firearm-related injuries in 2020. Additionally, according to the same source, the number of gunshot wounds grew by 14% between 2019 and 2020 and 25% during the previous five years. Similarly, according to NCBI, 78.2 million people suffer injuries from car accidents each year, whereas, in the next 20 years, this number is anticipated to increase by almost 65%. Hence, as a result of the aforementioned reasons, the acute wound segment is estimated to propel over the forecast duration.

End-use Insights

The hospital segment held the largest revenue share of 45.33% in 2021. The dominance of this market segment may be attributed to the rise in surgical procedures because of sedentary lifestyles worldwide, along with the rise in bariatric procedures, which demand the use of hydrogel dressing solutions to avoid surgical site infections. In addition, hospitals have long-term contracts with suppliers and are recognized as bulk buyer of hydrogel dressing. Moreover, according to Smith & Nephew, in a typical hospital setting, patients with wounds occupy between 25 and 40% of beds. Hence, owing to such factors, the segment is anticipated to grow during the forecast period.

The home healthcare segment is anticipated to witness the fastest CAGR of 4.95% during the forecast period due to patient’s growing demand shift from hospital to home care settings. Most procedures have a lengthy healing phase, which necessitates regular dressing changes. Additionally, elderly people with wounds prefer home care over hospitalization. Global geriatric population growth can be accredited for the growth of hydrogel dressing market. According to the Economic and Social Commission for Asia and the Pacific, there will be 1.3 billion older people worldwide in 2050, up from 630 million in 2020. In a similar manner, 13.6% of the Asia-Pacific region is predicted to have a quarter of the world's elderly population by 2050, thereby, boosting the growth of the market.

Additionally, a growing number of people with chronic diseases opt to receive treatment at home due to escalating healthcare costs. As hydrogel dressings are used to treat, diagnose, and monitor a variety of chronic and acute wounds, this trend is anticipated to increase demand for them. Therefore, it is projected that these factors will accelerate segment expansion during the forecast period.

Regional Insights

North America dominated the hydrogel dressing market with a revenue share of 45.51% in 2021 and is expected to witness a considerable growth rate in the forecast period. The large population bases and expanding patient pools in countries like the U.S. and Canada are the main factors driving the expansion of the hydrogel dressing industry in this area. Additionally, the growing diabetic population is projected to drive increased demand for hydrogel dressing supplies in this area because diabetics are more likely to develop chronic wounds.

For instance, according to the American Diabetes Association, there are over 1.9 million Americans with type 1 diabetes, including around 244,000 adolescents and teenagers. In contrast, 37.3 million Americans were predicted to have diabetes in 2019. Further, the market for hydrogel dressing products in North America is also anticipated to increase because of the rising number of gunshot wounds, traumatic accidents, and the availability of qualified specialists in this region.

Asia Pacific is estimated to witness the highest CAGR of 4.95% during the forecast period. This can be linked to the region's increased chronic diseases and obesity caused by changing lifestyles. For instance, according to Asia Development Bank Institute, there are around 1 billion overweight and obese people in the Asia Pacific region, which is the highest population in the world. Moreover, as per a similar source, in the Asia Pacific region, 2 out of 5 adults are either overweight or obese. Obese people are more susceptible to other chronic diseases such as diabetes, venous leg ulcers, pressure ulcers, thereby impelling the hydrogel dressing market in the region.

The increase in surgical procedures in this area is also anticipated to fuel market expansion. For instance, according to Business Insider, South Korea performs the most cosmetic procedures worldwide. As a result of the factors mentioned above, the Asia-Pacific is predicted to see the hydrogel dressing market's fastest growth rate.

Key Players

  • Cardinal Health
  • Smith & Nephew
  • 3M
  • Coloplast Corp.
  • ConvaTec Group PLC
  • Medline Industries, Inc.
  • Integra LifeSciences Corp.
  • McKesson Medical-Surgical
  • DermaRite Industries, LLC
  • AMERX Health Care Corp.

Market Segmentation

  • By Product Outlook
    • Amorphous Hydrogel
    • Impregnated Hydrogel
    • Sheet Hydrogel
  • By Application Outlook
    • Acute Wounds
      • Surgical & Traumatic Wounds
      • Burns
    • Chronic Wounds
      • Diabetic Foot Ulcers
      • Pressure Ulcers
      • Venous Leg Ulcers
      • Other Chronic Wounds
  • By End-use Outlook
    • Hospitals
    • Specialty Clinics
    • Home Healthcare
    • Others
  • By Regional Outlook
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
    • Asia Pacific
      • Japan
      • China
      • India
      • Australia
      • South Korea
    • Latin America
      • Brazil
      • Argentina
      • Mexico
      • Colombia
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Hydrogel Dressing Market 

5.1. COVID-19 Landscape: Hydrogel Dressing Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Hydrogel Dressing Market, By Product

8.1. Hydrogel Dressing Market, by Product, 2022-2030

8.1.1 Amorphous Hydrogel

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Impregnated Hydrogel

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Sheet Hydrogel

8.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Hydrogel Dressing Market, By Application

9.1. Hydrogel Dressing Market, by Application, 2022-2030

9.1.1. Acute Wounds

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Chronic Wounds

9.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Hydrogel Dressing Market, By End-use 

10.1. Hydrogel Dressing Market, by End-use, 2022-2030

10.1.1. Hospitals

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Specialty Clinics

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Home Healthcare

10.1.3.1. Market Revenue and Forecast (2017-2030)

10.1.4. Others

10.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Hydrogel Dressing Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Product (2017-2030)

11.1.2. Market Revenue and Forecast, by Application (2017-2030)

11.1.3. Market Revenue and Forecast, by End-use (2017-2030)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Product (2017-2030)

11.1.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.1.4.3. Market Revenue and Forecast, by End-use (2017-2030)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Product (2017-2030)

11.1.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.1.5.3. Market Revenue and Forecast, by End-use (2017-2030)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Product (2017-2030)

11.2.2. Market Revenue and Forecast, by Application (2017-2030)

11.2.3. Market Revenue and Forecast, by End-use (2017-2030)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Product (2017-2030)

11.2.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.2.4.3. Market Revenue and Forecast, by End-use (2017-2030)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Product (2017-2030)

11.2.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.2.5.3. Market Revenue and Forecast, by End-use (2017-2030)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Product (2017-2030)

11.2.6.2. Market Revenue and Forecast, by Application (2017-2030)

11.2.6.3. Market Revenue and Forecast, by End-use (2017-2030)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Product (2017-2030)

11.2.7.2. Market Revenue and Forecast, by Application (2017-2030)

11.2.7.3. Market Revenue and Forecast, by End-use (2017-2030)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Product (2017-2030)

11.3.2. Market Revenue and Forecast, by Application (2017-2030)

11.3.3. Market Revenue and Forecast, by End-use (2017-2030)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Product (2017-2030)

11.3.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.3.4.3. Market Revenue and Forecast, by End-use (2017-2030)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Product (2017-2030)

11.3.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.3.5.3. Market Revenue and Forecast, by End-use (2017-2030)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Product (2017-2030)

11.3.6.2. Market Revenue and Forecast, by Application (2017-2030)

11.3.6.3. Market Revenue and Forecast, by End-use (2017-2030)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Product (2017-2030)

11.3.7.2. Market Revenue and Forecast, by Application (2017-2030)

11.3.7.3. Market Revenue and Forecast, by End-use (2017-2030)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Product (2017-2030)

11.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.4.3. Market Revenue and Forecast, by End-use (2017-2030)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Product (2017-2030)

11.4.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.4.4.3. Market Revenue and Forecast, by End-use (2017-2030)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Product (2017-2030)

11.4.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.4.5.3. Market Revenue and Forecast, by End-use (2017-2030)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Product (2017-2030)

11.4.6.2. Market Revenue and Forecast, by Application (2017-2030)

11.4.6.3. Market Revenue and Forecast, by End-use (2017-2030)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Product (2017-2030)

11.4.7.2. Market Revenue and Forecast, by Application (2017-2030)

11.4.7.3. Market Revenue and Forecast, by End-use (2017-2030)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Product (2017-2030)

11.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.5.3. Market Revenue and Forecast, by End-use (2017-2030)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Product (2017-2030)

11.5.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.5.4.3. Market Revenue and Forecast, by End-use (2017-2030)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Product (2017-2030)

11.5.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.5.5.3. Market Revenue and Forecast, by End-use (2017-2030)

Chapter 12. Company Profiles

12.1. Cardinal Health

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Smith & Nephew

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. 3M

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Coloplast Corp.

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. ConvaTec Group PLC

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Medline Industries, Inc.

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Integra LifeSciences Corp.

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. McKesson Medical-Surgical

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. DermaRite Industries, LLC

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. AMERX Health Care Corp.

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers